Draft Japanese Pharmacopoeia Crude Drug Standards 2026 – Public Comment
日本薬局方外生薬規格2026（案）に関する御意見の募集について
Published: 2026-10-06 · Source: e-Gov Public Comment · Stage: Public Comment Open · Area: Healthcare / Pharmaceuticals · Impact (preliminary): Medium · Comment deadline: 2026-11-05 00:00 JST · First detected by this dashboard: 2026-10-06
View the original Japanese source More Healthcare / Pharmaceuticals updates Search all updates in the dashboard
AI summary
Generated by AI from the Japanese source metadata. It is an unofficial monitoring aid, not legal advice, and may contain errors. The area, stage, and impact labels are preliminary keyword-based triage labels. Confirm every point in the original Japanese source.
Summary
The Ministry of Health, Labour and Welfare is seeking public comments on a draft of the 'Japanese Pharmacopoeia Crude Drug Standards 2026' (Nihon Yakkyokuho-gai Seiyaku Kikaku 2026). The draft was announced on 2026-10-06, and the comment period is listed as closing on 2026-11-05 at 00:00. The inquiry contact is the Pharmaceutical Evaluation Division of the Pharmaceutical Safety Bureau at the Ministry.
Business Impact
If finalized, the standards could be relevant to companies that manufacture, import, or handle crude drugs and related products in Japan. The actual scope and effect cannot be determined from the metadata provided.
Recommended Action
Consider reviewing the official Japanese public comment notice and the attached draft documents to confirm the content, scope, and submission procedure before the stated deadline.